Pridinol

This classification denotes an antipsychotic agent with the molecular formula C20H25NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9E75Q6SUUB, chemically known as 1,1-diphenyl-3-piperidino-1-propanol but generally known as pridinol, which bears US NIH Compound Identifier 4904. European Medicines Agency schedules Pridinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10037MIG. The term PRIDINOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules pridinol in its Anatomical Therapeutic Chemical (ATC) Classification. PRIDINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pridinol under HS 29333999 and SITC 51574. As of Q4 2014, PRIDINOL remains the US FDA Preferred Term for this commodity. Pridinol bears US NLM identifiers UMLS ID C0071968 and NCI Concept Code C73319. SMILES: OC(CCN1CCCCC1)(C1CCCCC1)C1CCCCC1.